Skip to content
XL18420mg

Drawing based on the label description. No photo yet.

“Capsules: 20-mg gelatin capsules, grey with "XL184 20mg" printed in black on the body of the capsule”

XL184 20mg pill

Pill with imprint XL184 20mg is gray, capsule, 19 mm and has been identified as Cabozantinib 20 mg. It is used for renal cell carcinoma. It is supplied by Exelixis, Inc.

Cabozantinib 20 mg

Imprint
XL184 20mg
Strength
20 mg
Used for
Renal cell carcinoma
Color
Gray
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Capsule
Manufacturer
Exelixis, Inc
Drug class
Cancer medicine (kinase inhibitor)
NDC
42388-011, 42388-011-14, 42388-012, 42388-012-14, 42388-013, 42388-013-14

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cabozantinib pills and guides

What is Cabozantinib used for?

Cabozantinib is used for renal cell carcinoma.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Renal Cell Carcinoma

CABOMETYX is indicated for the treatment of patients with advanced renal cell carcinoma (RCC).

CABOMETYX, in combination with nivolumab, is indicated for the first-line treatment of patients with advanced RCC.

Hepatocellular Carcinoma

CABOMETYX is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.

Differentiated Thyroid Cancer

CABOMETYX is indicated for the treatment of adult and pediatric patients 12 years of age and older with locally advanced or metastatic differentiated thyroid cancer (DTC) that has progressed following prior VEGFR-targeted therapy and who are radioactive iodine-refractory or ineligible.

Neuroendocrine Tumors

CABOMETYX is indicated for the treatment of adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic neuroendocrine tumors (pNET).

CABOMETYX is indicated for the treatment of adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated extra-pancreatic neuroendocrine tumors (epNET).

From the FDA-approved label on DailyMed (published Nov 17, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows XL184 20mg. The parts can be split between the two sides, so turn the pill over and check both.
  • It is gray, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Cometriq.

One of the pills in the Cometriq pack.

Ingredients

Active: Cabozantinib S-Malate

Inactive: Cellulose, Microcrystalline, Croscarmellose Sodium, Sodium Starch Glycolate Type A Potato, Silicon Dioxide, Stearic Acid, Gelatin, Ferrosoferric Oxide, Titanium Dioxide, Shellac, Butyl Alcohol, Isopropyl Alcohol, Propylene Glycol, Ammonia

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Cabozantinib pills